Supply and Delivery of Live Attenuated Influenza Vaccine (LAIV) 2026/2027 Flu Season
Awarded
The competition has ended and a winner has been selected.
- Procedure
- Without prior noticeTwo stages
- Agreement
- Buying goods
- Estimated value
- €1
Brief
Health Service Executive (HSE) has entered into an agreement with AstraZeneca AB for the supply and delivery of Live Attenuated Influenza Vaccine (LAIV) for the 2026/2027 Flu Season in Dublin, with a final contract value of 1 EUR. The contract is for 12 months and aims to provide sufficient stock to vaccinate relevant cohorts against Influenza. Only one bid was received for this contract.
Farmasøytisk engroshandel
Result
- AstraZeneca ABWinner
- 1Number of tenders received
- €1Contract value
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Negotiated under Article 32(2)b
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Health Service Executive (HSE)
From the notice
In accordance with the National Immunisation Advisory Committee Immunisation Guidelines of Ireland a National Contract for the Supply of Live Attenuated Influenza Vaccines (LAIV) to the HSE is required to vaccinate relevant cohorts and provide protection against Influenza. This contract will provide sufficient stock of LAIV to vaccinate relevant cohorts for the next 12 months. There is only one sole supplier of Live Attenuated Influenza Vaccines (LAIV) in Ireland.
Contact
procurement.helpdesk@hse.ie- Result · PrequalificationType
- DublinLocation
- 33651600Main codeVaccines